Joiner M C, Rojas A, Johns H
CRC Gray Laboratory, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom.
Radiat Res. 1992 May;130(2):227-35.
Measurements of renal damage in the mouse were made to determine if there was an equal effect per fraction during a course of repeated 240-kVp X-ray doses. An X-ray dose of 2 Gy was given 2, 8, 14, or 20 times with interfraction intervals of 12 h. Some animals were also irradiated with twenty 2-Gy doses using a 5-h interfraction interval. The underlying effect per fraction (-logeSF of the notional target cell population) was determined from the additional top-up dose of d(4)-Be neutrons needed to produce measurable renal impairment assessed by decreased clearance from the plasma of [51Cr]EDTA and by a reduction in the hematocrit at 25, 29, 33, and 39 weeks after treatment. There was no significant influence of the time of assay on the values of underlying effect measured. A mean value of underlying effect was therefore calculated for the two different assays of each mouse, from the measurements at the four times. This gave approximately 40 estimates (one for each animal assessed) with each assay of the effectiveness of 2-Gy fractions in each of the four fractionation schedules, a total of 321 determinations in the study with 12-h intervals. Regression analysis showed that there was no significant trend in underlying effect per fraction with number of fractions, i.e., the damage per fraction was constant regardless of the number of fractions used. With underlying effect normalized to 1 unit of damage for a single 2-Gy dose, the slope of this plot was -0.0013 per fraction2 +/- 0.0097 (95% CL). The assumption of equal effect per fraction was therefore not invalidated in the kidney of the mouse. With a 5- instead of a 12-h interfraction interval, the 20-fraction schedule was 7% more effective as measured by the two assays analyzed together; this was significant at P = 0.0001. This shows that 5 h is not sufficient time between fractions for full repair to occur in the kidney, and underlines the need for intervals of at least 6 h between the doses in clinical radiotherapy using more than one fraction per day. The data are consistent with an alpha/beta ratio approximately 1.6 Gy, with a repair half-time approximately 1.3 h. However, these experiments were not designed to determine these parameters and their values should be regarded only as rough estimates.
对小鼠的肾损伤进行了测量,以确定在重复给予240 kVp X射线剂量的疗程中,每次分割剂量的效应是否相同。以12小时的分割间期给予2 Gy的X射线剂量,分别照射2次、8次、14次或20次。一些动物还以5小时的分割间期接受了20次2 Gy剂量的照射。根据为产生可测量的肾损伤所需额外补充的d(4)-Be中子剂量,确定每次分割剂量的潜在效应(名义靶细胞群的-log eSF),肾损伤通过[51Cr]EDTA从血浆中的清除率降低以及治疗后25周、29周、33周和39周时血细胞比容的降低来评估。检测时间对所测量的潜在效应值没有显著影响。因此,根据每只小鼠在四个时间点的测量值,计算了每种小鼠两种不同检测方法的潜在效应平均值。这在每个分割方案中对2 Gy分割剂量的有效性检测中给出了约40个估计值(每只评估动物一个),在12小时间隔的研究中总共进行了321次测定。回归分析表明,每次分割剂量的潜在效应与分割次数之间没有显著趋势,即无论使用的分割次数如何,每次分割的损伤是恒定的。将单次2 Gy剂量的潜在效应归一化为1个损伤单位,该图的斜率为每次分割-0.0013±0.0097(95%置信区间)。因此,每次分割剂量效应相同的假设在小鼠肾脏中并未被推翻。当分割间期为5小时而非12小时时,通过综合分析的两种检测方法测量,20次分割方案的有效性高7%;这在P = 0.0001时具有显著性。这表明分割之间5小时的时间不足以使肾脏完全修复,并强调了在临床放疗中每天使用多个分割剂量时,剂量之间至少需要6小时的间隔。这些数据与α/β比值约为1.6 Gy、修复半衰期约为1.3小时一致。然而,这些实验并非旨在确定这些参数,其值应仅视为粗略估计。